These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antimicrobial and non-antimicrobial tetracyclines in human cancer trials. Richards C; Pantanowitz L; Dezube BJ Pharmacol Res; 2011 Feb; 63(2):151-6. PubMed ID: 20951804 [TBL] [Abstract][Full Text] [Related]
12. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266 [TBL] [Abstract][Full Text] [Related]
13. Role of Chemically Modified Tetracyclines in the Management of Periodontal Diseases: A Review. Ghangurde AA; Ganji KK; Bhongade ML; Sehdev B Drug Res (Stuttg); 2017 May; 67(5):258-265. PubMed ID: 28268238 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531 [TBL] [Abstract][Full Text] [Related]
15. Treating periodontal diseases by blocking tissue-destructive enzymes. Golub LM; Wolff M; Roberts S; Lee HM; Leung M; Payonk GS J Am Dent Assoc; 1994 Feb; 125(2):163-9; discussion 169-71. PubMed ID: 8113524 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their inhibition in periodontal treatment. Ryan ME; Ramamurthy S; Golub LM Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573 [TBL] [Abstract][Full Text] [Related]
17. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Ryan ME; Usman A; Ramamurthy NS; Golub LM; Greenwald RA Curr Med Chem; 2001 Feb; 8(3):305-16. PubMed ID: 11172685 [TBL] [Abstract][Full Text] [Related]
18. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. Greenwald RA; Golub LM; Lavietes B; Ramamurthy NS; Gruber B; Laskin RS; McNamara TF J Rheumatol; 1987 Feb; 14(1):28-32. PubMed ID: 3033237 [TBL] [Abstract][Full Text] [Related]
19. Periodontal therapeutics: Current host-modulation agents and future directions. Golub LM; Lee HM Periodontol 2000; 2020 Feb; 82(1):186-204. PubMed ID: 31850625 [TBL] [Abstract][Full Text] [Related]
20. Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. Golub LM; Elburki MS; Walker C; Ryan M; Sorsa T; Tenenbaum H; Goldberg M; Wolff M; Gu Y Int Dent J; 2016 Jun; 66(3):127-35. PubMed ID: 27009489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]